← Evidence map

TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Methotrexate, Doxorubicin, and Cisplatin Versus Methotrexate, Doxorubicin, and Cisplatin + Ifosfamide in Poor Responders to Preoperative Chemotherapy for Newly Diagnosed High-Grade Osteosarcoma (JCOG0905): A Multicenter, Open-Label, Randomized Trial.

Hiroaki Hiraga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40138604